Researchers have found that a new vaccine for malaria may be more than 70% effective on children in a phase II clinical trial in Burkina Faso. No other vaccine comes close to that. The public health impacts could be far-reaching if the results continue in further trials, Halidou Tinto tells host Marco Werman. He is a professor of parasitology and principal investigator at the Clinical Research Unit of Nanoro, in Burkina Faso.
We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!